ENDRA Life Sciences Inc (NDRA)

NASDAQ:NDRA

NDRA

ENDRA Life Sciences

RESEARCH TOOLSreports

ENDRA Life Sciences (NDRA) Price & Analysis

857 Followers

NDRA Stock Chart & Stats

$4.69

-$0.12(-1.95%)

At close: Jan 08 4:00 PM EST

$4.69

-$0.12(-1.95%)

Day’s Range― - ―

52-Week Range$2.90 - $11.96

Previous CloseN/A

Volume13.45K

Average Volume (3M)514.97K

Market Cap

$6.13M

Enterprise Value$3.45M

Total Cash (Recent Filing)$762.37K

Total Debt (Recent Filing)$492.35K

Price to Earnings (P/E)―

Beta1.03

Next Earnings

May 14, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-3.26

Shares Outstanding1,240,751

10 Day Avg. Volume1,472,495

30 Day Avg. Volume514,968

Financial Highlights & Ratios

PEG Ratio0.04

Price to Book (P/B)1.58

Price to Sales (P/S)0.00

P/FCF Ratio-0.69

Enterprise Value/Market Cap0.56

Enterprise Value/RevenueN/A

Enterprise Value/Gross Profit-21.92

Enterprise Value/Ebitda-0.65

Forecast

1Y Price Target

$27.00

Price Target Upside475.69% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering1

EPS Forecast (FY)-4.62

Revenue Forecast (FY)$100.00K

Bulls Say, Bears Say

Bulls Say

Market OpportunityThe launch of the TAEUS application for early detection of Steatotic Liver Disease opens a large market opportunity.

Product DevelopmentENDRA's TAEUS platform offers a cost-effective alternative to CT and MRI, enabling new ways to visualize human tissue composition at the point-of-care.

Bears Say

Price TargetThe 12-month price target for ENDRA has been lowered from $50 to $46, despite maintaining a BUY rating.

Revenue GenerationENDRA is a late stage medical device development/early stage commercialization company so it generates no revenues.

ENDRA Life Sciences News

Endra Life Sciences reports Q4 EPS ($8.93) vs ($56.94) last year

“Over the past year we significantly strengthened the clinical foundation for TAEUS, demonstrating performance that we believe positions...

13d ago

NDRA

Endra Life Sciences initiates review of strategic alternatives

ENDRA Life Sciences (NDRA)’ Board of Directors has initiated a process to evaluate a range of strategic alternatives...

19d ago

NDRA

ENDRA Life Sciences Explores Strategic Alternatives Amid Restructuring

ENDRA Life Sciences ( ($NDRA) ) has issued an update. On March 25, 2026, ENDRA Life Sciences said...

19d ago

NDRA

Is NDRA a Buy, Before Earnings?

Endra Life Sciences (NDRA) is scheduled to report 4th quarter earnings on 03/26/2026. Regarding Q4 estimates, Wall Street...

20d ago

NDRA

Endra Life Sciences announces favorable TAEUS liver device study results

Endra Life Sciences (NDRA) announced favorable results from a clinical study evaluating the measurement consistency of its TAEUS...

2M ago

NDRA

Endra Life Sciences announces results from Taeus Liver device feasibility study

Endra Life Sciences (NDRA) announced new results from its 2025 Taeus Liver device feasibility study demonstrating that Taeus’...

4M ago

NDRA

Endra Life Sciences (NDRA) Q3 Earnings Cheat Sheet

Endra Life Sciences (NDRA) is scheduled to report 3rd quarter earnings on 11/17/2025. Regarding Q3 estimates, Wall Street...

5M ago

NDRA

ENDRA Life Sciences Reports Q3 2025 Financial Results

Endra Life Sciences ( ($NDRA) ) has released its Q3 earnings. Here is a breakdown of the information...

5M ago

NDRA

ENDRA Life Sciences Granted Nasdaq Compliance Extension

ENDRA Life Sciences ( ($NDRA) ) just unveiled an announcement. On October 31, 2025, ENDRA Life Sciences received...

5M ago

NDRA

Endra Life Sciences commences staking of HYPE digital asset holdings

ENDRA Life Sciences (NDRA) announced it has commenced staking its holdings of HYPE (HYPE-USD), the native token of...

5M ago

NDRA

Endra Life Sciences files to sell 2.68M shares of common stock for holders

The company will not receive any proceeds from the sale of shares by the selling stockholders. Published first...

5M ago

NDRA

ENDRA Life Sciences Signs Sales Agreement with Lucid

An announcement from ENDRA Life Sciences ( ($NDRA) ) is now available. On October 29, 2025, ENDRA Life...

6M ago

NDRA

Endra Life Sciences reports Q2 EPS ($1.71) vs. (8c) last year

As of June 30, 2025, ENDRA reported $1.8 million in cash and cash equivalents, providing resources to execute...

8M ago

NDRA

ENDRA Life Sciences Forms Cryptocurrency Advisory Board

An announcement from ENDRA Life Sciences ( ($NDRA) ) is now available. ENDRA Life Sciences Inc. has initiated...

9M ago

NDRA

NDRA FAQ

What was ENDRA Life Sciences Inc’s price range in the past 12 months?

ENDRA Life Sciences Inc lowest stock price was $2.90 and its highest was $11.96 in the past 12 months.

What is ENDRA Life Sciences Inc’s market cap?

ENDRA Life Sciences Inc’s market cap is $6.13M.

When is ENDRA Life Sciences Inc’s upcoming earnings report date?

ENDRA Life Sciences Inc’s upcoming earnings report date is May 14, 2026 which is in 31 days.

How were ENDRA Life Sciences Inc’s earnings last quarter?

ENDRA Life Sciences Inc released its earnings results on Mar 31, 2026. The company reported -$3.26 earnings per share for the quarter, missing the consensus estimate of -$1.23 by -$2.03.

Is ENDRA Life Sciences Inc overvalued?

According to Wall Street analysts ENDRA Life Sciences Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does ENDRA Life Sciences Inc pay dividends?

ENDRA Life Sciences Inc does not currently pay dividends.

What is ENDRA Life Sciences Inc’s EPS estimate?

ENDRA Life Sciences Inc’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does ENDRA Life Sciences Inc have?

ENDRA Life Sciences Inc has 1,240,751 shares outstanding.

What happened to ENDRA Life Sciences Inc’s price movement after its last earnings report?

ENDRA Life Sciences Inc reported an EPS of -$3.26 in its last earnings report, missing expectations of -$1.23. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of ENDRA Life Sciences Inc?

Currently, no hedge funds are holding shares in NDRA

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

ENDRA Life Sciences Inc

ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in temperature monitoring of thermoablative surgery, vascular imaging, and tissue perfusion. It also offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. The company has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.

ENDRA Life Sciences (NDRA) Earnings & Revenues

Historic Earnings Reports

NDRA Stock 12 Month Forecast

Average Price Target

$27.00

▲(475.69% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"2":"$2","2153":"$2,153","539.75":"$539.8","1077.5":"$1,077.5","1615.25":"$1,615.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":27,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$27.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":27,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$27.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":27,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$27.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[2,539.75,1077.5,1615.25,2153],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jun<br/>2024","6":"Jan<br/>2025","9":"Dec<br/>2025","12":"Apr<br/>2026","25":"Apr<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4.65,6.36923076923077,8.088461538461539,9.807692307692308,11.526923076923078,13.246153846153847,14.965384615384616,16.684615384615384,18.403846153846153,20.123076923076923,21.842307692307692,23.56153846153846,25.28076923076923,{"y":27,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4.65,6.36923076923077,8.088461538461539,9.807692307692308,11.526923076923078,13.246153846153847,14.965384615384616,16.684615384615384,18.403846153846153,20.123076923076923,21.842307692307692,23.56153846153846,25.28076923076923,{"y":27,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4.65,6.36923076923077,8.088461538461539,9.807692307692308,11.526923076923078,13.246153846153847,14.965384615384616,16.684615384615384,18.403846153846153,20.123076923076923,21.842307692307692,23.56153846153846,25.28076923076923,{"y":27,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":2152.5,"date":1690848000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1612.62,"date":1698796800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":705.42,"date":1711929600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":470.75,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.39,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.76,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.26,"date":1735689600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":3.92,"date":1743465600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 14</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":7.2,"date":1746057600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 13</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":5.89,"date":1764547200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 10</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":4.53,"date":1767225600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":3.58,"date":1769904000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":4.65,"date":1775001600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >